Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination

作者
Jordi Reina,Carla Iglesias
出处
期刊:Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia [Sociedad Española de Quimioterapia]
卷期号:35 (3): 236-240 被引量:60
标识
DOI:10.37201/req/002.2022
摘要

All coronavirus, including SARS-CoV-2, encode two proteases needed for the processing of PP1A and PP1AB polyproteins. The main protease 3CL (chemotripsine-like) gives rise to the formation of NSP11/16 proteins. The 3CL protease has been constituted as one of the possible therapeutic targets for the development of antiviral drugs against SARS-COV-2 due to its highly conserved sequence and structure among all coronaviruses. During the SARS-COV-1 pandemic, a hydroxymethyl ketone derivative (PF-00835231) was identified with an intense inhibitory activity against the 3CL protease. Subsequent chemical modifications gave rise to derivative PF-07321332 (nirmatrelvir) which has shown a high antiviral efficacy against SARS-COV-2. The company's data indicate that it is capable of reducing 89% the risk of hospitalization and death of patients infected with hardly adverse effects. Its effectiveness improves if it is administered orally in the first 24-48 hours and the duration of treatment has been established between 3-5 days. The commercial form has been associated with the antiviral ritonavir that has shown the metabolism of nirmatrelvir, lengthening its average life. This antiviral would be effective against current and future viral variants, since 3CL is not modified in them. The FDA approved this antiviral in November 2021 and EMA is in the final evaluation phase.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被zheng采纳,获得10
刚刚
gabizheng发布了新的文献求助10
刚刚
史萌发布了新的文献求助10
刚刚
叶落风遇雨完成签到 ,获得积分10
刚刚
kai发布了新的文献求助10
1秒前
1秒前
1秒前
4秒前
橘子味汽水完成签到,获得积分20
5秒前
羊羊羊发布了新的文献求助10
6秒前
6秒前
在水一方的应助被111采纳,获得10
7秒前
华仔的应助被DW采纳,获得10
9秒前
9秒前
充电宝的应助被史萌采纳,获得10
9秒前
SciGPT的应助被星辰采纳,获得10
10秒前
5007完成签到,获得积分10
10秒前
10秒前
11秒前
西麓麓发布了新的文献求助10
12秒前
所所的应助被白华苍松采纳,获得10
12秒前
12秒前
syvshc的应助被科研通管家采纳,获得10
13秒前
momo完成签到,获得积分10
13秒前
Hello的应助被科研通管家采纳,获得10
13秒前
科研大人完成签到,获得积分10
13秒前
羊羊羊完成签到,获得积分10
13秒前
无花果的应助被科研通管家采纳,获得10
13秒前
丘比特的应助被科研通管家采纳,获得10
13秒前
思源的应助被科研通管家采纳,获得10
13秒前
星辰大海的应助被科研通管家采纳,获得10
13秒前
13秒前
13秒前
14秒前
14秒前
大模型的应助被科研通管家采纳,获得10
14秒前
情怀的应助被科研通管家采纳,获得10
14秒前
14秒前
852的应助被科研通管家采纳,获得10
14秒前
秋风的应助被科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196